Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Watchlists
My Portfolio
Markets
News
Videos
Yahoo Finance Plus
Screeners
Personal Finance
Crypto
Sectors
Contact Us
Advertisement
U.S. markets open in 5 hours 27 minutes
S&P Futures
5,304.75
-3.50
(-0.07%)
Dow Futures
40,105.00
-39.00
(-0.10%)
Nasdaq Futures
18,503.00
-0.75
(-0.00%)
Russell 2000 Futures
2,134.90
-3.50
(-0.16%)
Crude Oil
81.73
+0.38
(+0.47%)
Gold
2,213.10
+0.40
(+0.02%)
Nektar Therapeutics (ITH.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Follow
0.8056
-0.0224
(-2.71%)
As of 08:05AM CET. Market open.
Summary
Company Insights
Chart
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Upgrade to begin using 40 years of financial statements and get so much more.
Download
Income Statement
Expand All
All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Learn more
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
90,122
90,122
92,055
101,907
152,915
Cost of Revenue
33,768
33,768
21,635
24,897
19,477
Gross Profit
56,354
56,354
70,420
77,010
133,438
Operating Expense
191,579
191,579
310,656
523,113
513,360
Operating Income
-135,225
-135,225
-240,236
-446,103
-379,922
Net Non Operating Interest Income Expense
-6,325
-6,325
-22,128
-44,582
-18,836
Other Income Expense
-134,706
-134,706
-102,619
-32,595
-45,189
Pretax Income
-276,256
-276,256
-364,983
-523,280
-443,947
Tax Provision
-200
-200
3,215
557
493
Net Income Common Stockholders
-276,056
-276,056
-368,198
-523,837
-444,440
Diluted NI Available to Com Stockholders
-276,056
-276,056
-368,198
-523,837
-444,440
Basic EPS
-1.55
-
-1.97
-2.86
-2.49
Diluted EPS
-1.55
-
-1.97
-2.86
-2.49
Basic Average Shares
189,301
-
187,138
183,298
178,581
Diluted Average Shares
189,301
-
187,138
183,298
178,581
Total Operating Income as Reported
-263,684
-263,684
-376,166
-446,103
-425,111
Total Expenses
225,347
225,347
332,291
548,010
532,837
Net Income from Continuing & Discontinued Operation
-276,056
-276,056
-368,198
-523,837
-444,440
Normalized Income
-147,690
-147,690
-287,221
-517,980
-411,452
Interest Income
19,009
19,009
6,783
2,731
18,282
Interest Expense
25,334
25,334
28,911
47,313
37,118
Net Interest Income
-6,325
-6,325
-22,128
-44,582
-18,836
EBIT
-250,922
-250,922
-336,072
-475,967
-406,829
EBITDA
-243,107
-243,107
-323,042
-461,821
-392,647
Reconciled Cost of Revenue
33,768
33,768
21,635
24,897
19,477
Reconciled Depreciation
7,815
7,815
13,030
14,146
14,182
Net Income from Continuing Operation Net Minority Interest
-276,056
-276,056
-368,198
-523,837
-444,440
Total Unusual Items Excluding Goodwill
-128,459
-128,459
-102,503
-8,023
-45,189
Total Unusual Items
-128,459
-128,459
-102,503
-8,023
-45,189
Normalized EBITDA
-114,648
-114,648
-220,539
-453,798
-347,458
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-93
-93
-21,526
-2,166
-12,201
Yahoo Finance Plus Essential access required.
Learn more
Advertisement
Advertisement
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your Privacy Choices
About Our Ads
Sitemap
© 2024 Yahoo. All rights reserved.